Joshua Liang is the founder of Clover Biopharmaceuticals. Clover Biopharmaceuticals has raised $1B in total funding. Latest round: IPO.
Joshua Liang is the Chief Executive Officer of Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel biologic therapies. Since joining in 2016, he has raised over $1 billion and overseen the company's growth to over 800 employees across more than 15 countries.
Full founder directory · Investor directory · Company funding database · Fundraising library